Abstract:Background: Bladder cancer is one of the most common malignancies in urologic system. The glucocorticoid-inducible kinase 2 (SGK2) expression and function were largely unknown in cancers. Current study was aimed to investigate the role of SGK2 in bladder cancer and its potential mechanisms. Methods: SGK2 expression was quantified by western blot (WB) in multiple bladder cancer cell lines (T24, 5637, J82 and UMUC3) compared with normal urothelial cell line (SVHUC). SGK2 knocking down and overexpression model were established by lentivirus transfection. MTT, colony formation, wound healing and transwell assay were used to assess the tumor cell proliferation, migration and invasion abilities, respectively. In addition, molecular function analysis was performed using FunRich software V3. Immunoprecipitation (IP) assay was applied to investigate the interaction between SGK2 and β-catenin at protein level. TCGA database was retrieved to verify the association between these genes and clinical tumor stage as well as prognosis among bladder cancer patients. Results: SGK2 expression was significantly upregulated in multiple bladder cancer cell lines compared with SVHUC at protein level. Cell proliferation, migration and invasion abilities were significantly decreased after knocking down SGK2 in J82 and UMUC3 cell lines. Inversely, cell aggressive phenotypes were significantly increased after overexpressing SGK2 in T24 cell line. Furthermore, functional analyses of SGK2 based on TCGA database showed that SGK2 related genes were involved in receptor activity, ATP binding, DNA repair protein, trans-membrane receptor activity and lipid binding. In addition, protein interaction analysis identified c-Myc was significantly enriched in SGK2 positively associated genes. The prediction was validated by WB and IP assay that SGK2 could directly bind with β-catenin at protein level to regulate their downstream gene c-Myc expression in bladder cancer to influence tumor progression. And clinical data generated from TCGA database also identified these downstream genes were significantly associated with tumor stage and survival status of bladder cancer patients. Conclusion: Taken together, our findings suggest SGK2 promotes bladder cancer progression via mediating β-catenin/c-Myc signaling pathway, which may serve as a potential therapeutic target for bladder cancer patients.

PI3K/Akt to GSK3β/β-catenin Signaling Cascade Coordinates Cell Colonization for Bladder Cancer Bone Metastasis Through Regulating ZEB1 Transcription.

HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model

The Role of ZBTB38 in Promoting Migration and Invasive Growth of Bladder Cancer Cells.

Cxcl5/Cxcr2 Axis Promotes Bladder Cancer Cell Migration And Invasion By Activating Pi3k/Akt-Induced Upregulation Of Mmp2/Mmp9

Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo.

Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer.

TGFβ1 Secreted by Cancer-Associated Fibroblasts Induces Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through Lncrna-Zeb2nat

Kinesin Family Member C1 Accelerates Bladder Cancer Cell Proliferation and Induces Epithelial–mesenchymal Transition Via Akt/GSK3β Signaling

TBK1 Promote Bladder Cancer Cell Proliferation and Migration Via Akt Signaling.

[Aberrant Expressions of Β-Catenin and ZEB1 in Bladder Cancer and Their Significance].

MET/SMAD3/SNAIL Circuit Mediated by Mir-323A-3p is Involved in Regulating Epithelial–mesenchymal Transition Progression in Bladder Cancer

DDR1a Promotes Tumor Invasion and Metastasis Via the ZEB1/COL4 Axis in Bladder Cancer

Correction For: ZNF139/circZNF139 Promotes Cell Proliferation, Migration and Invasion Via Activation of PI3K/AKT Pathway in Bladder Cancer

Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.

The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer

CRYAB Inhibits Migration and Invasion of Bladder Cancer Cells Through the PI3K/AKT and ERK Pathways.

A Novel Pi3k/Akt Signaling Axis Mediates Nectin-4-Induced Gallbladder Cancer Cell Proliferation, Metastasis and Tumor Growth

Glucocorticoid-Inducible Kinase 2 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Enhancing Β-Catenin/c-myc Signaling Pathway.

C-Met and CREB1 Are Involved in Mir-433-mediated Inhibition of the Epithelial–mesenchymal Transition in Bladder Cancer by Regulating Akt/GSK-3β/Snail Signaling

TGF-β-induced Transgelin Promotes Bladder Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition and Invadopodia Formation

Α-E-catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer.